Literature DB >> 25722288

PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.

Laura A Jansen1, Ghayda M Mirzaa2, Gisele E Ishak3, Brian J O'Roak4, Joseph B Hiatt5, William H Roden6, Sonya A Gunter7, Susan L Christian6, Sarah Collins6, Carissa Adams6, Jean-Baptiste Rivière8, Judith St-Onge8, Jeffrey G Ojemann9, Jay Shendure5, Robert F Hevner10, William B Dobyns2.   

Abstract

Malformations of cortical development containing dysplastic neuronal and glial elements, including hemimegalencephaly and focal cortical dysplasia, are common causes of intractable paediatric epilepsy. In this study we performed multiplex targeted sequencing of 10 genes in the PI3K/AKT pathway on brain tissue from 33 children who underwent surgical resection of dysplastic cortex for the treatment of intractable epilepsy. Sequencing results were correlated with clinical, imaging, pathological and immunohistological phenotypes. We identified mosaic activating mutations in PIK3CA and AKT3 in this cohort, including cancer-associated hotspot PIK3CA mutations in dysplastic megalencephaly, hemimegalencephaly, and focal cortical dysplasia type IIa. In addition, a germline PTEN mutation was identified in a male with hemimegalencephaly but no peripheral manifestations of the PTEN hamartoma tumour syndrome. A spectrum of clinical, imaging and pathological abnormalities was found in this cohort. While patients with more severe brain imaging abnormalities and systemic manifestations were more likely to have detected mutations, routine histopathological studies did not predict mutation status. In addition, elevated levels of phosphorylated S6 ribosomal protein were identified in both neurons and astrocytes of all hemimegalencephaly and focal cortical dysplasia type II specimens, regardless of the presence or absence of detected PI3K/AKT pathway mutations. In contrast, expression patterns of the T308 and S473 phosphorylated forms of AKT and in vitro AKT kinase activities discriminated between mutation-positive dysplasia cortex, mutation-negative dysplasia cortex, and non-dysplasia epilepsy cortex. Our findings identify PI3K/AKT pathway mutations as an important cause of epileptogenic brain malformations and establish megalencephaly, hemimegalencephaly, and focal cortical dysplasia as part of a single pathogenic spectrum.
© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  brain development; childhood epilepsy; malformations of cortical development; molecular genetics

Mesh:

Substances:

Year:  2015        PMID: 25722288      PMCID: PMC4614119          DOI: 10.1093/brain/awv045

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  75 in total

1.  FGFR3, PIK3CA and RAS mutations in benign lichenoid keratosis.

Authors:  L Groesser; E Herschberger; M Landthaler; C Hafner
Journal:  Br J Dermatol       Date:  2012-03-14       Impact factor: 9.302

2.  Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease.

Authors:  C H Kwon; X Zhu; J Zhang; L L Knoop; R Tharp; R J Smeyne; C G Eberhart; P C Burger; S J Baker
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

3.  Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease.

Authors:  S A Backman; V Stambolic; A Suzuki; J Haight; A Elia; J Pretorius; M S Tsao; P Shannon; B Bolon; G O Ivy; T W Mak
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

4.  Causes of epilepsies: insights from discordant monozygous twins.

Authors:  R S Briellmann; G D Jackson; Y Torn-Broers; S F Berkovic
Journal:  Ann Neurol       Date:  2001-01       Impact factor: 10.422

5.  Somatic activation of AKT3 causes hemispheric developmental brain malformations.

Authors:  Annapurna Poduri; Gilad D Evrony; Xuyu Cai; Princess Christina Elhosary; Rameen Beroukhim; Maria K Lehtinen; L Benjamin Hills; Erin L Heinzen; Anthony Hill; R Sean Hill; Brenda J Barry; Blaise F D Bourgeois; James J Riviello; A James Barkovich; Peter M Black; Keith L Ligon; Christopher A Walsh
Journal:  Neuron       Date:  2012-04-12       Impact factor: 17.173

Review 6.  Mutations of the human PTEN gene.

Authors:  D Bonneau; M Longy
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

7.  Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome.

Authors:  Kyle C Kurek; Valerie L Luks; Ugur M Ayturk; Ahmad I Alomari; Steven J Fishman; Samantha A Spencer; John B Mulliken; Margot E Bowen; Guilherme L Yamamoto; Harry P W Kozakewich; Matthew L Warman
Journal:  Am J Hum Genet       Date:  2012-05-31       Impact factor: 11.025

Review 8.  PI3K and mTOR signaling pathways in cancer: new data on targeted therapies.

Authors:  Lise Willems; Jerome Tamburini; Nicolas Chapuis; Catherine Lacombe; Patrick Mayeux; Didier Bouscary
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

9.  Focal dysplasia of the cerebral cortex and infantile spasms associated with somatic 1q21.1-q44 duplication including the AKT3 gene.

Authors:  V Conti; M Pantaleo; C Barba; G Baroni; D Mei; A M Buccoliero; S Giglio; F Giordano; S T Baek; J G Gleeson; R Guerrini
Journal:  Clin Genet       Date:  2014-10-07       Impact factor: 4.438

10.  Evidence for mTOR pathway activation in a spectrum of epilepsy-associated pathologies.

Authors:  Joan Liu; Cheryl Reeves; Zuzanna Michalak; Antonietta Coppola; Beate Diehl; Sanjay M Sisodiya; Maria Thom
Journal:  Acta Neuropathol Commun       Date:  2014-07-08       Impact factor: 7.801

View more
  123 in total

1.  De novo PIK3R2 variant causes polymicrogyria, corpus callosum hyperplasia and focal cortical dysplasia.

Authors:  Gaetano Terrone; Norine Voisin; Ali Abdullah Alfaiz; Gerarda Cappuccio; Giuseppina Vitiello; Nicolas Guex; Alessandra D'Amico; A James Barkovich; Nicola Brunetti-Pierri; Ennio Del Giudice; Alexandre Reymond
Journal:  Eur J Hum Genet       Date:  2016-02-10       Impact factor: 4.246

2.  The mTOR pathway in treatment of epilepsy: a clinical update.

Authors:  Jennifer L Griffith; Michael Wong
Journal:  Future Neurol       Date:  2018-05-29

3.  Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.

Authors:  Jae Seok Lim; Ramu Gopalappa; Se Hoon Kim; Suresh Ramakrishna; Minji Lee; Woo-Il Kim; Junho Kim; Sang Min Park; Junehawk Lee; Jung-Hwa Oh; Heung Dong Kim; Chang-Hwan Park; Joon Soo Lee; Sangwoo Kim; Dong Seok Kim; Jung Min Han; Hoon-Chul Kang; Hyongbum Henry Kim; Jeong Ho Lee
Journal:  Am J Hum Genet       Date:  2017-02-16       Impact factor: 11.025

4.  The enlarging spectrum of focal cortical dysplasias.

Authors:  Peter B Crino
Journal:  Brain       Date:  2015-06       Impact factor: 13.501

Review 5.  The role of somatic mutational events in the pathogenesis of epilepsy.

Authors:  Philip H Iffland; Peter B Crino
Journal:  Curr Opin Neurol       Date:  2019-04       Impact factor: 5.710

6.  Malformations of Cerebral Cortex Development: Molecules and Mechanisms.

Authors:  Gordana Juric-Sekhar; Robert F Hevner
Journal:  Annu Rev Pathol       Date:  2019-01-24       Impact factor: 23.472

Review 7.  Dysplasia and overgrowth: magnetic resonance imaging of pediatric brain abnormalities secondary to alterations in the mechanistic target of rapamycin pathway.

Authors:  Shai Shrot; Misun Hwang; Carl E Stafstrom; Thierry A G M Huisman; Bruno P Soares
Journal:  Neuroradiology       Date:  2017-12-26       Impact factor: 2.804

8.  A novel missense mutation in the HECT domain of NEDD4L identified in a girl with periventricular nodular heterotopia, polymicrogyria and cleft palate.

Authors:  Koji Kato; Fuyuki Miya; Ikumi Hori; Daisuke Ieda; Kei Ohashi; Yutaka Negishi; Ayako Hattori; Nobuhiko Okamoto; Mitsuhiro Kato; Tatsuhiko Tsunoda; Mami Yamasaki; Yonehiro Kanemura; Kenjiro Kosaki; Shinji Saitoh
Journal:  J Hum Genet       Date:  2017-05-18       Impact factor: 3.172

Review 9.  The mTOR signalling cascade: paving new roads to cure neurological disease.

Authors:  Peter B Crino
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

10.  Genome Sequencing of Autism-Affected Families Reveals Disruption of Putative Noncoding Regulatory DNA.

Authors:  Tychele N Turner; Fereydoun Hormozdiari; Michael H Duyzend; Sarah A McClymont; Paul W Hook; Ivan Iossifov; Archana Raja; Carl Baker; Kendra Hoekzema; Holly A Stessman; Michael C Zody; Bradley J Nelson; John Huddleston; Richard Sandstrom; Joshua D Smith; David Hanna; James M Swanson; Elaine M Faustman; Michael J Bamshad; John Stamatoyannopoulos; Deborah A Nickerson; Andrew S McCallion; Robert Darnell; Evan E Eichler
Journal:  Am J Hum Genet       Date:  2015-12-31       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.